December 5, 2023 01:22 PM ESTUpdated 05:45 PM

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

Kyle LaHucik

Senior Reporter

Andrew Dunn

Senior Biopharma Correspondent

Resonance Medicine, a two-year-old stealth-stage biotech out of the lab of famed biochemist David Liu, has decided to shut down, Endpoints News has learned. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

Kyle LaHucik

Senior Reporter

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Scoop: Res­o­nance Med­i­cine, a pro­tease biotech from David Liu’s lab, shuts down

Senior Reporter

Senior Biopharma Correspondent

Sign up to read this article for free.

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down